Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Professor Matthew Collin
Newcastle Authors
Title
Year
Full text
Dr Venetia Bigley
Professor Matthew Collin
2B or not 2B is the question in DC ontogeny
2025
Professor Matthew Collin
A comparison of cryopreserved and noncryopreserved peripheral blood hematopoietic stem cells for autologous transplantation in multiple myeloma: a study from the chronic malignancies working party of the EBMT
2025
Professor Matthew Collin
Dr Paul Milne
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease
2025
Professor Matthew Collin
Impact of Wilms’ tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry
2025
Professor Matthew Collin
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)
2025
Trevor Liddle
Professor Matthew Collin
Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention
2025
Professor Matthew Collin
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts
2025
Professor Matthew Collin
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study
2024
Professor Matthew Collin
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
2024
Dr Callum Wright
Dr Kim Pearce
Sarah Pagan
Louise Duncan
Jamie Macdonald
et al.
Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation: a single centre retrospective study
2024
Professor Matthew Collin
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2024
Dr Simon Bomken
Professor Matthew Collin
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures
2024
Professor Matthew Collin
Risk factors for
Nocardia
infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
2024
Professor Matthew Collin
Autologous hematopoietic cell transplantation (autoHCT) for T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study
2023
Professor Matthew Collin
Histiocytes set on the heart: cardiac complications of Erdheim-Chester disease
2023
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15